Abvc Biopharma, Inc.
- Last sale
- Nov 12, 2026 · -2.42%
- Market cap
- $26.17M
- 26.98M shares
- Filings
- 803
FY 2025−41.9% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q2 2026derivedN/M FY23 yoy
Q3 2026N/M FY25 yoy
Q3 2026+174.4% FY25 yoy
- $26.17M
- —
- 88.4×
- 2.0×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $296,000 | reported | |
| FY 2024 | 2024-12-31 | $509,589 revised | reported | |
| FY 2023 | 2023-12-31 | $152,430 | reported | |
| FY 2022 | 2022-12-31 | $969,783 | reported | |
| FY 2021 | 2021-12-31 | $355,797 | reported | |
| FY 2020 | 2020-12-31 | $483,045 | reported | |
| FY 2019 | 2019-12-31 | $701,719 | reported | |
| FY 2018 | 2018-12-31 | $6,956 | reported | |
| FY 2015 | 2015-12-31 | $50,000,000 | reported | |
| FY 2014 | 2014-09-18 | $0 | reported | |
| FY 2013 | 2013-09-30 | $7,787 | reported |
Segments
Geography
LineFY2025ShareChange
In Taiwan$8.10M63%—
In USA$4.74M37%—
Total$12.84M
Pharmaceutical preparations
Abvc Biopharma, Inc. is the 235th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
SCNXScienture Holdings, Inc.$431.6K215.9%9,618.0%$120.3MMNOVMedicinova Inc$409.7K—2,928.8%$72.0MCANFCan-Fite BioPharma Ltd.$405.0K39.9%2,426.7%$1.9MPVCTProvectus Biopharmaceuticals, Inc.$336.1K45.5%1,615.8%$29.2MALLRAllarity Therapeutics, Inc.$320.0K—3,509.7%$14.7MHINDVyome Holdings, Inc$319.7K96.0%3,209.7%$11.1M
ABVCAbvc Biopharma, Inc. (this company)$296.0K41.9%2,671.8%$26.2M
GDTCCytoMed Therapeutics Ltd$252.3K395.9%1,227.1%$9.8MRGBPRegen BioPharma Inc$236.6K0.0%538.8%$393.7KPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Abvc Biopharma, Inc. · CIK 1173313 · Engraved from SEC EDGAR